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Copper isanessentialmicronutrient that isnecessary forhealthy
immune function. This requirement is underscored by an in-
creasedsusceptibility tobacterial infection incopper-deficientani-
mals; however, a molecular understanding of its importance in
immune defense is unknown. In this study, we investigated the
effect of proinflammatory agents on copper homeostasis in
RAW264.7 macrophages. Interferon- was found to increase
expressionof thehigh affinity copper importer, CTR1, and stim-
ulate copper uptake. This was accompanied by copper-stimu-
lated trafficking of the ATP7A copper exporter from the Golgi
to vesicles that partially overlapped with phagosomal compart-
ments. Silencing of ATP7A expression attenuated bacterial kill-
ing, suggesting a role for ATP7A-dependent copper transport
in the bactericidal activity of macrophages. Significantly, a
copper-sensitive mutant of Escherichia coli lacking the CopA
copper-transporting ATPase was hypersensitive to killing by
RAW264.7 macrophages, and this phenotype was dependent
on ATP7A expression. Collectively, these data suggest that
copper-transporting ATPases, CopA and ATP7A, in both bac-
teria and macrophage are unique determinants of bacteria sur-
vival and identify an unexpected role for copper at the host-
pathogen interface.
Copper is an essential nutrient for aerobic organisms. Its
ability to exchange electrons as it cycles between cuprous
and cupric states has been harnessed by enzymes that cata-
lyze a wide variety of biochemical processes (1). However,
this same redox activity also confers copper with toxic prop-
erties when it is present in the free ionic form. Free copper can
participate in Fenton-like chemistry to produce the highly toxic
hydroxyl radical from hydrogen peroxide and superoxide
(2–4). It is therefore not surprising that organisms have evolved
tightly regulated mechanisms for copper transport and intra-
cellular distribution.
Copper is among several micronutrients found to be impor-
tant for both innate and adaptive immunity (5, 6). Copper defi-
ciency decreases interleukin-2 secretion in T cells (7), and
recent studies have demonstrated a direct role for copper in the
secretion of interleukin 1- and fibroblast growth factor-1 (8).
Various studies have shown that copper-deficient animals are
susceptible to several pathogens, including Candida albicans
(9, 10), Pasteurella hemolytica (11), Trypanosoma lewisi (12),
and Salmonella typhimurium (13). Other studies have shown
that copper supplementation is protective against Escherichia
coli-induced mastitis in dairy cattle (14). In vitro studies have
shown that copper deficiency impairs the bactericidal activity
of neutrophils and macrophages (15, 16). Moreover, a recent
study demonstrated that copper concentrations are markedly
increased within the phagosomal compartment of macro-
phages activated by interferon- (IFN-)3 andMycobacterium
avium (18). Although these studies provide indirect evidence of
a role for copper in immune defense, an understanding of the
underlying processes at a molecular level is lacking.
Here we report dramatic changes in copper homeostasis
triggered by proinflammatory agents in macrophages, a
phagocytic cell type of the innate immune system. These
changes include elevated expression of the CTR1 copper im-
porter, increased copper uptake, and copper-stimulated traf-
ficking of the ATP7A copper transporter from the Golgi to
cytoplasmic vesicles that overlap with the phagosomal com-
partment. Significantly, silencing of ATP7A impaired bacteri-
cidal activity, suggesting that copper transport via ATP7A was
required for bacterial killing. Consistent with this role, a cop-
per-sensitive mutant of E. coli with a defect in copper export
was significantly more sensitive to macrophage-mediated killing
thanwild type cells, and this sensitivity was dependent onATP7A
expression. These findings suggest that copper-transporting
ATPases present within both macrophage and bacteria are novel
determinants of this host-pathogen interaction.
EXPERIMENTAL PROCEDURES
Cell Culture—RAW264.7 cells were obtained from the Ameri-
can Type Culture Collection and were maintained in Dulbecco’s
modified Eagle’s medium (Invitrogen) containing 10% fetal
bovine serum and 100 units/ml penicillin and streptomycin
(Invitrogen) in 5% CO2 at 37 °C. ATP7A-silenced RAW264.7
cells were generated by stable transfection of a pRS vector har-
boring a 29-nucleotide short hairpin RNA against ATP7A (Ori-
gene, Rockville, MD) and selected in 25 g/ml puromycin
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(Invitrogen). Control cells were transfected with the same vec-
tor expressing short hairpin RNA against green fluorescent
protein (Origene). The Rab7-Q67L plasmid was transiently
transfected into RAW264.7 cells using Lipofectamine 2000
(Invitrogen) according to the manufacturer’s instructions.
Copper Uptake Studies—64Cu uptake was assayed as de-
scribed previously with minor modifications (19). RAW264.7
macrophage cells in triplicate 6-well trays were cultured
overnight in 1 ml of serum-free medium with or without the
indicated concentrations of IFN- (BD Biosciences) or LPS
(Sigma). Cells were then incubated with serum-free medium
containing 1 M 64Cu for 5 min, washed extensively in ice-cold
phosphate-buffered saline, and scraped into phosphate-buff-
ered saline. Radioactivity was measured using a  counter, and
counts were determined per total protein concentration.
Bacterial Survival Assays—RAW264.7 cells alone or trans-
fected with control RNAi or ATP7A RNAi plasmids were acti-
vated by overnight treatment in serum-freemediumcontaining
25 ng/ml IFN-.Where indicated, either 20MCuCl2 or 50M
ebselen was also added to the cells. Cells were then detached by
scraping into ice-cold serum-free medium, washed twice, and
resuspended in triplicate in serum-free medium. Wild type
E. coli (strain W3110) or the copA deletion strain (DW3110) (20,
21) were grown to stationary phase and added to the RAW264.7
macrophages at amacrophage/bacteria ratio of 1:10 or 1:1. Bacte-
rial phagocytosis was allowed to proceed for 30 min at 37 °C, and
the extracellular bacteria were removed by twowasheswith phos-
phate-buffered saline containing 12.5 g/ml gentamicin (Invitro-
gen). One set of samples (uptake group) was lysed in 0.1% Triton
X-100 solution andplatedontoLB-agarplates for colony counting
to provide bacterial uptake values. The remaining set (kill group)
was incubated for 1 or 2 h (as indicated) at 37 °C in serum-free
medium to allow bacterial killing to occur, lysed, and then plated
onto LB-agar. Colony numbers were normalized against the total
protein content of each sample, and bacterial survival was deter-
mined by dividing the number of colonies in the killing group by
those in the uptake group.
In Vitro Bactericidal Assay—The in vitro survival assay was
performed as previously described (22). Briefly, exponential
phase cultures of E. coli were pelleted and resuspended in 1 ml
of assay buffer (0.1 M sodium phosphate, pH 7.4, 0.15 M NaCl,
and 0.5 mM ascorbic acid to act as a reducing agent) in the
presence or absence of 500MH2O2, 10Mcopper, or both, for
20 min at 37 °C. Serial dilutions of bacteria were plated, and
bacterial survival rates were expressed as a percentage of the
untreated group in assay buffer alone.
Immunological Techniques—Immunofluorescence micros-
copy and Western blot analysis were performed as described
previously (23).
Latex Bead Phagocytosis and Phagosome Purification—
RAW264.7 cells were activated by overnight treatment with 25
ng/ml IFN- and exposed to a 1:200 dilution of 3-m latex
beads (Sigma) for 90 min at 37 °C to allow phagocytosis to pro-
ceed. Cells were thenwashedwith phosphate-buffered saline to
remove extracellular beads and fixed in paraformaldehyde and
processed for immunofluorescence as above. In other experi-
ments, bead-containing phagosomes were purified by sucrose
gradient centrifugation as described previously (24).
Ceruloplasmin Activity—Conditioned medium was concen-
trated using Amicon Ultra-4 filter tubes (Millipore), and ceru-
loplasmin activity was assayed as described previously (25).
RESULTS
Copper Enhances the Bactericidal Activity of Macrophages—
We began this study by testing whether copper supplementa-
tion to the growthmedium of the murine macrophage cell line,
FIGURE 1. Copper enhances bacterial killing by RAW264.7 macrophage
cells. A, RAW264.7 macrophages were treated with 25 ng/ml IFN- in the
presence or absence of 20M copper prior to exposure to E. coli for 30min to
allow phagocytosis to occur. After removal of extracellular bacteria, bacterial
survival was measured following incubations for 1 or 2 h at 37 °C and
expressed as a percentage of initial internalized E. coli (mean  S.D.; n  3;
p 0.05, Student’s t test). B, in vitro bacterial survival was assessed following
exposure of E. coli to 0.5 mM H2O2, 10 M CuCl2 or H2O2 plus CuCl2. Bacterial
survival rates were calculated and expressed as percentage survival com-
paredwith theuntreatedgroup (mean S.D.;n3;p0.05).Different letters
signify values of significant difference (Tukey’s post hoc analysis). C, bacterial
survival was assayed after 2 h in IFN--treated RAW264.7macrophages in the
presence or absence of 20 M copper and a 50 M concentration of the anti-
oxidant ebselen (mean S.D.; n 3; p 0.05, one- and two-way analysis of
variance). Different letters signify values of significant difference (Tukey’spost
hoc analysis).
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RAW264.7,might alter its bactericidal activity. Cells were stim-
ulated overnight with the proinflammatory cytokine, IFN-, in
the presence or absence of 20M copper, and their ability to kill
E. coli was determined the following day. In the RAW264.7
macrophages pretreatedwith copper, bacterial survival was sig-
nificantly reduced relative to untreated cells following either a
1- or 2-h incubation (Fig. 1A). There was no effect of copper on
the uptake of bacteria by RAW264.7 cells (data not shown).
These findings suggest that copper can potentiate the bacteri-
cidal activity of RAW264.7 cells. Previous in vitro studies have
demonstrated that bacteria are highly sensitive to low concen-
trations of Cu in the presence of hydrogen peroxide (H2O2)
(22), and we confirmed these findings in our study (Fig. 1B).
These data underscored the possibility that the enhanced bac-
tericidal activity conferred by the copper treatment of macro-
phages may be dependent on reactive oxygen species. This
hypothesis was supported by the finding that pretreating the
RAW264.7 macrophage cells with ebselen, a cell-permeable
glutathione peroxidase mimetic, prevented the copper-medi-
ated increase in bactericidal activity (Fig. 1C). Ebselen treat-
ments did not alter the rate of phagocytosis of E. coli compared
with control RAW264.7 cells (data not shown). Taken together,
FIGURE 2. Proinflammatory agents stimulate copper uptake and CTR1
expression in RAW264.7 cells. A, copper uptake activity. RAW264.7 cells
were pretreated with serum-freemediumwith or without IFN- or LPS at the
indicated concentrations for 24 h, and copper uptake in the presence of 1M
64Cuwasmeasured over 5min and expressed per total protein concentration
(mean S.D.; n 3; *, p 0.05, Student’s t test). B, Western blot analysis of
CTR1 protein levels in total cell lysates of RAW264.7 macrophage cells
exposed for 24 h to a range of IFN- and LPS concentrations. Relative band
intensities against tubulin are shown in parentheses.
FIGURE 3. Proinflammatory agents stimulate ATP7A expression in
RAW264.7 cells.Western blot analysis of ATP7A protein levels in total cell
lysates of RAW264.7macrophage cells exposed for 24 h to a range of IFN-
(A) and LPS concentrations (B). Relative band intensities against tubulin
are shown in parentheses.
FIGURE 4. Lipopolysaccharide and IFN- induce trafficking of ATP7A in
RAW264.7 cells. Shown is immunofluorescence analysis of ATP7A protein in
RAW264.7 cells grown for 24 h in the presence of 100 ng/ml LPS, 25 ng/ml
IFN-, or 20 M CuCl2. Cells were fixed, permeabilized, and probed with anti-
bodies against ATP7A and anti-rabbit antibodies conjugated to Alexa-488
(green) or antibodies against the Golgi marker GM130 and anti-mouse anti-
bodies conjugated to Alexa-594 (red). Nuclei were labeled with 4,6-di-
amidino-2-phenylindole (blue).
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these findings suggest that copper can promote the bactericidal
activityofRAW264.7macrophages ina reactiveoxygenspecies-
dependent manner.
Inflammatory Mediators Induce the Expression of CTR1 and
ATP7A Copper Transporters—Since copper was found to po-
tentiate the bacteridical activity of RAW264.7 cells, we in-
vestigated whether copper homeostasis might be altered
in these cells following stimulation with proinflammatory
agents. Treatment of RAW264.7 macrophages with the proin-
flammatory agents, IFN- or LPS, stimulated copper uptake
activity in a dose-dependent manner (Fig. 2A). Immunoblot
analysis indicated that these effects of IFN- and LPS were
associated with a dose-dependent increase in the expression of
the copper importer, CTR1 (Fig. 2C). Taken together, these
findings suggest that the inflammatory response of macro-
phages stimulates CTR1-mediated copper uptake.
We then investigated the effect of proinflammatory agents
on another copper transporter, ATP7A, a copper-transporting
P-typeATPase responsible for delivering copper from the cyto-
plasm into secretory compartments. Immunoblot analysis
demonstrated that both IFN- and LPS treatments increased
the expression of ATP7A protein in RAW264.7 cells (Fig. 3, A
and B). A closely related copper transporter to ATP7A, known
as ATP7B, was not expressed in these cells (data not shown).
Taken together, these results suggest that the stimulation of
macrophages by LPS or IFN- promotes copper uptake and
increases expression of CTR1 and ATP7A proteins.
IFN- and LPS Stimulate Copper-dependent ATP7A Traf-
ficking to Post-Golgi Vesicles That Overlap with the Phagosome—
Previous studies have demonstrated that elevated intracellular
copper levels stimulate the trafficking of the ATP7A pro-
tein from the trans-Golgi network to post-Golgi vesicles in a
variety of cell types (26–29). Given that IFN- or LPS stimu-
lated copper uptake and increased cellular copper levels, we
surmised that these proinflammatory agents might also stimu-
late ATP7A trafficking. Using immunofluorescence micros-
copy, the ATP7A protein was identified in the perinuclear
region of untreated RAW264.7 macrophages, consistent with
its location in the trans-Golgi network (Fig. 4, top panels). As
expected, the addition of copper to the culture medium stimu-
lated the trafficking of ATP7A to post-Golgi vesicles (Fig. 4,
second from top panels). Interestingly, when RAW264.7 cells
were exposed to IFN- or LPS without copper supplementa-
tion, the ATP7A protein was also distributed to post-Golgi ves-
icles, although these punctaewere not as clearly associatedwith
the cell periphery as in the case of copper treatment (Fig. 4,
third and fourth from top panels). The location of the Golgi
matrix marker protein, GM130, was not altered by IFN- or
LPS, suggesting that the shift inATP7Adistributionwas not the
result of general Golgi disruption (Fig. 4). Because the traffick-
ing of ATP7A is known to be responsive to copper, we exam-
ined whether these effects of IFN- could be inhibited using
the membrane-permeable copper chelator tetrathiomolybdate
FIGURE 5. The trafficking of ATP7A in response to IFN- is copper-de-
pendent. A, IFN--induced trafficking of ATP7A is inhibited by the copper
chelator TTM. RAW264.7 cells were cultured for 24 h in the presence of IFN-
with or without 10 nM TTM. ATP7A protein was detected by immunofluores-
cencemicroscopy after cellswere fixed, permeabilized, andprobedwith anti-
bodies against ATP7A and anti-rabbit antibodies conjugated to Alexa-488
(green). B, tetrathiomolybdate does not inhibit the increase in ATP7A protein
expressionduring inflammation. RAW264.7were treated for 24hwith serum-
free medium alone or the same medium containing 100 ng/ml LPS or 25
ng/ml IFN- in the presence or absence of 10 nM TTM. ATP7A protein was
detected in total cell lysates by Western blot analysis. Relative band intensi-
ties against tubulin are shown in parentheses.
FIGURE 6. Time course analysis of IFN--stimulated ATP7A trafficking
and expression. Shown are immunofluorescence analysis (A) and Western
blot analysis (B) of ATP7A protein in RAW264.7 cells exposed to 25 ng/ml
IFN- for the indicated times. Relative band intensities against tubulin are
shown in parentheses.
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(TTM). The treatment of RAW264.7 cells with TTM blocked
IFN--stimulated trafficking of ATP7A, consistent with a role
for copper in this trafficking process (Fig. 5A). Importantly,
Western blot analysis of these same cells demonstrated that the
increased expression of ATP7A in response to either IFN- or
LPS was not blocked by TTM (Fig. 5B). This finding indicated
that the inhibition of trafficking by TTM was not due to sup-
pression of ATP7A expression. In support of this conclusion,
ATP7A trafficking was apparent within 3 h of IFN- treatment
(Fig. 6A), whereas the increases in ATP7A protein expression
required a longer time period (Fig. 6B).
We then examined whether IFN-might trigger the traffick-
ing of ATP7A to the phagosomal compartment. The phagocy-
tosis of latex beads was used to identify phagosomes in IFN--
stimulated RAW264.7 cells (Fig. 7A, Bright field), and ATP7A
was then detected in the same cells using immunofluorescence
microscopy (Fig. 7B). There was clear labeling of ATP7A out-
lining the periphery of compartments that also contained the
internalized beads, suggesting the presence of ATP7A within
phagosomes in IFN--treated cells
(Fig. 7B). In separate experiments,
phagosomal membranes were puri-
fied from IFN--treated RAW264.7
cells by subcellular fractionation
of membranes containing the in-
ternalized latex beads. Immuno-
blot analysis of this fraction dem-
onstrated a marked enrichment of
the phagolysosomal marker LAMP-1
relative to total cell lysates, as well
as abundant levels of ATP7A pro-
tein (Fig. 7C). The phagosomal
fraction lacked the Golgi marker
protein, GM130, indicating that the
detection of ATP7A in these frac-
tions was not an artifact of Golgi
contamination (Fig. 7C). Further
studies investigated whether ATP7A
partially colocalizedwith a constitu-
tively active mutant of Rab7, a
GTPase involved in late endosome
fusion and required for lysosomal
biogenesis (30–32). The constitu-
tively active mutant Rab7-Q67L is
useful for co-localization studies
because it results in enlarged lysoso-
mal structures (30). RAW264.7 cells
were transiently transfected with
green fluorescent protein-tagged
Rab7-Q67L and then exposed for
24 h to basal medium or medium
containing 25 ng/ml IFN-. As
shown in Fig. 7, in untreated cells
there was little overlap between the
perinuclear location of ATP7A and
Rab7-Q67L-containing compart-
ments (Fig. 7D). However, in cells
stimulated with IFN-, the ATP7A
protein was found to partially overlap with Rab7-Q67L-
containing compartments (Fig. 7D). Taken together, these
studies suggest that IFN- activation of macrophages is asso-
ciated with partial redistribution of ATP7A to the phagoly-
sosomal compartment.
ATP7A-dependent Copper Transport Is Required for Bacteri-
cidal Activity of RAW264.7 Macrophages—The above findings
highlight the possibility that ATP7A-dependent copper
transport into the phagosome might be important for mac-
rophage microbiocidal activity. To test this hypothesis, we
investigated the effect of RNAi-mediated depletion of ATP7A
on bacterial killing in RAW264.7 cells. Stable transfection of
a 29-nucleotide short hairpin RNAi plasmid against ATP7A
resulted in robust silencing ofATP7A gene expression (ATP7A
RNAi cells), relative to control cells transfected with an irrele-
vant RNAi against green fluorescent protein (Fig. 8A). We then
confirmed that ATP7A-dependent copper transport was sup-
pressed in the ATP7A RNAi cells by testing the activity of copper-
dependent enzyme, ceruloplasmin, a ferroxidase whose expres-
FIGURE 7. IFN- stimulates partial trafficking of the ATP7A protein to the phagosomal compartment in
RAW264.7 macrophages. A, partial co-localization of ATP7A with phagosomal membranes. RAW264.7 mac-
rophageswere stimulatedovernightwith IFN-andallowed tophagocytose latexbeads to allow identification
of the phagosomal compartments (Bright field). B, ATP7Awas detected by immunofluorescencemicroscopy in
the same cells as in A. C, co-fractionation of ATP7A with the phagosomal membrane marker Lamp-1. IFN--
stimulated RAW264.7 cells were allowed to phagocytose latex beads, and the phagosomal compartment was
isolated via subcellular fractionation. The bead fraction and total protein fractionwere subjected to SDS-PAGE.
Immunoblot analysis revealed abundant ATP7A in Lamp-1-positive bead fraction, which lacked the Golgi
marker protein GM130. Note that Lamp-1 was poorly detected in total lysates. D, partial co-localization of
ATP7A with Rab7-Q67L in IFN--stimulated RAW264.7 cells. Cells were transiently transfected with green
fluorescent protein-tagged Rab7-Q67L plasmid and then exposed for 24 h to basal medium or medium con-
taining25ng/ml IFN-. Cellswere fixed, permeabilized, andprobedwith antibodies againstATP7A followedby
anti-rabbit antibodies conjugated to Alexa-594.
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sion is stimulated by IFN-. As expected, ceruloplasmin protein
expression was stimulated by IFN- in both ATP7A RNAi and
control cells (Fig. 8B). Because ceruloplasmin activity requires
copper transport into secretory compartments, it can serve as a
biomarker of ATP7A function. As shown in Fig. 8C, ceruloplas-
min activity was markedly reduced in the ATP7A RNAi cells
treated with IFN-, suggesting that the ATP7A-dependent
copper delivery to ceruloplasmin was reduced in these cells.
Control experiments confirmed this by showing that cerulo-
plasmin activity could be restored after the addition of excess
exogenous copper to ATP7A RNAi cells to bypass ATP7A-me-
diated copper transport (Fig. 8C).
Having confirmed a reduction in ATP7A-mediated copper
transport activity in the ATP7A RNAi cells, we examined this
effect on bacterial killing. E. coli killing experiments demon-
strated a higher bacterial survival in ATP7A RNAi cells relative
to control cells (Fig. 8D). This defect in bacterial killing was
bypassed by pretreatment of ATP7A RNAi cells with excess
exogenous copper, indicating that
the reduced bacterial killing was
attributable to a copper transport
defect rather than an unrelated
defect in the ATP7A-depleted cells
(Fig. 8D). These findings support
the hypothesis that ATP7A-de-
pendent copper transport into the
phagosome is important for the bac-
tericidal activity of macrophages.
We further explored the role of
copper homeostasis in bacteri-
cidal killing by testing whether the
ability of E. coli to export copper
might influence its susceptibility
to killing by RAW264.7 macro-
phages. The copA mutant strain
of E. coli is hypersensitive to ele-
vated copper concentrations due to
the role of the CopA protein in the
extrusion of copper from the cyto-
plasm (33). The CopA protein is a
copper-transporting P-type ATPase
belonging to the same subfamily as
the ATP7A protein. The copA
mutant was markedly more suscep-
tible to killing by RAW264.7macro-
phages compared with its parental
wild type E. coli strain (Fig. 9A). Sig-
nificantly, the susceptibility of the
copA strain was dependent on
ATP7A protein in the macrophage
host because its survival was in-
creased in ATP7A RNAi cells rel-
ative to control cells (Fig. 9B). Col-
lectively, these data suggest that
bacterial CopA and mammalian
ATP7A are unique determinants
of macrophage-dependent bacterial
killing and identify an unexpected
role for copper in host-pathogen interactions.
DISCUSSION
Copper has long been recognized as a biocidal agent. Its
modern day use in algaecides, fungicides, antimicrobial sur-
faces, and medical devices can be traced back to its early use in
the treatment of wounds by ancient Egyptian and Roman civi-
lizations (34). In this study, we identify for the first time that
specific changes in macrophage copper homeostasis mediate
bacterial killing. Macrophage activation by proinflammatory
agents triggered increased copper uptake activity and a striking
copper-dependent relocalization of the ATP7A protein to a
vesicular distribution, which partially overlappedwith the phago-
somal compartment. In support of this trafficking event, a
recent analysis of the macrophage phagosomal proteome iden-
tified ATP7A in this compartment (35). Significantly, macro-
phage-mediated bacterial killing was dependent on the expres-
sion of the ATP7A copper transporter, as evidenced by the
FIGURE 8. E. coli survival is dependent on ATP7A expression in RAW264.7 macrophages. A, immunoblot
analysis of ATP7Aprotein in RAW264.7 cells stably transfectedwith either ATP7ARNAi or control RNAi. B, West-
ern blot analysis of ceruloplasmin protein in concentrated conditioned medium collected from ATP7A RNAi
and control RNAi cells treated for 24 h in the presence or absence of 25 ng/ml IFN-. Note that ceruloplasmin
basal expression or induction by IFN- is not impaired by ATP7A depletion. C, ceruloplasmin activity was
assayed from concentrated conditioned medium from control RNAi or ATP7A RNAi macrophages treated for
24 h in the presence or absence of 20 M CuCl2. Values were normalized against total protein content of each
sample (mean S.D.; n 3; two-way analysis of variance). Note the suppression of ceruloplasmin activity in
ATP7A-depleted cells and the rescue by the addition of copper. D, survival of wild type E. coli in control RNAi-
or ATP7A RNAi-transfected RAW264.7 cells pretreated overnight with 25 ng/ml IFN- in the presence or
absence of 20 M CuCl2. Note that bacterial survival was significantly increased in ATP7A-depleted cells com-
paredwith control cells and that copper pretreatment of ATP7A-depleted cells restored bactericidal activity to
control levels (mean S.D.; n 3; two-way analysis of variance).
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attenuated bactericidal activity when ATP7A was silenced.
These findings suggest that copper transport into the phago-
some via the ATP7A protein is a novel determinant of bac-
terial killing by macrophages. Consistent with this hypothesis,
recent studies using x-ray microprobe analysis have demon-
strated that copper levels within the phagosome increase
10-fold to180M in IFN--stimulatedmacrophages exposed
toM. avium (18).
Howmight this enrichment of copper promote bacterial kill-
ing by macrophages? One possibility is the copper-catalyzed
production of the hydroxyl radical from hydrogen peroxide via
Fenton-like chemistry. Although hydrogen peroxide is gener-
ated spontaneously from superoxide created by the respiratory
burst, it is only lethal to bacteria at supraphysiological millimo-
lar concentrations (36). However, physiological concentrations
of hydrogen peroxide and cuprous ions are lethal to E. coli (22).
Iron-mediated hydroxyl radical production is also toxic to bac-
teria in vitro (37); however, a role for iron in macrophage bac-
tericidal activity is unlikely because iron accumulation in the
phagosome is decreased in IFN--stimulated macrophages,
and iron treatment of macrophages reduces bactericidal activ-
ity (38). These findings, together with those of our study, sug-
gest that a lethal combination of copper and hydrogen peroxide
may be the underlying mechanism by which ATP7A-depen-
dent copper transport into the phagosome promotes bacterial
killing.
An important finding of our study was that the copper-sen-
sitive copA mutant of E. coli was more susceptible to macro-
phage-mediated killing than the wild type strain. Because the
CopA protein functions in the extrusion of cytoplasmic copper
across the plasma membrane (33), these findings suggest that
copper export is a bacterial defense mechanism against macro-
phage-mediated killing. Consistent with this hypothesis, the
susceptibility of thecopAmutant to killingwas ameliorated by
depletion of ATP7A in RAW264.7 macrophage cells. These
findings suggest that copper transport by both host and patho-
gen is a unique and mutually opposing tactic in the struggle for
supremacy; i.e. ATP7A-mediated copper transport into the
phagosome appears to be countered by copper extrusion by the
bacterium. Indeed, there is evidence to suggest that copper
exportmight be a defense strategy that is generally applicable to
other pathogenic bacteria. For example, the virulence of
Pseudomonas aeruginosa inmice is severely decreased (20-fold)
by mutations in the copper exporter, CueA (39). Additionally,
the expression of several metal ion exporters, including two
putative copper efflux transporters, CopA1 and CopA2, are
induced in Legionella pneumophila upon phagocytosis bymac-
rophages (40). Moreover, plasmids that increase the virulence
of Klebsiella pneumoniae and Shigella sonnei harbor putative
copper resistance genes (41, 42).
In light of our findings, it is notable that bacterial infections,
especially those of the respiratory tract, are commonly reported
in infants with Menkes disease, in whom genetic mutations in
the ATP7A gene give rise to copper deficiency (43–46). How-
ever, it is uncertain whether this susceptibility to infections
arises from defects in ATP7A-dependent activities of macro-
phages or impairment of other copper-requiring processes.
Deciphering the role of ATP7A in innate immunity in vivo will
requiremyeloid-specific ATP7A knock-outmice, which we are
currently generating.
It is notable that changes in the serum concentration of
micronutrients following infection are characteristic of the
acute phase inflammatory response. Serum levels of iron,
zinc, selenium, retinol, riboflavin, and pyridoxine are all
reported to decrease following inflammatory insult (47). The
proposed physiological rationale for these changes is nutri-
ent deprivation to limit proliferation of the invadingmicrobe
(47). A well documented example is the contest between host
and pathogen over limiting iron stores, which plays a critical
role in determining the outcome of infection (48). In con-
trast, however, systemic copper concentrations are widely
reported to increase in response to acute and chronic inflam-
mation (49–65). Although the secreted copper-containing
protein, ceruloplasmin, is partially responsible for this rise in
serum copper (66), the non-protein-bound fraction of copper
in the serum is also increased during inflammation (49). More-
over, radiotracer studies with 64Cu have demonstrated that
copper accumulates at sites of inflammation (67) andwithin the
exudates of wounds and burns where there exists an abundance
FIGURE 9. The bacterial copper exporter, CopA, is a determinant of E. coli
survival in RAW264.7 macrophages. A, the survival of wild type (Wt) and
copA deletion mutant E. coli in IFN- stimulated RAW264.7 macrophages.
The percentage survival data is shown for 1 and 2 h kill times (postuptake)
(mean  S.D.; n  3). B, the killing of copA mutant E. coli is attenuated in
ATP7A-depleted RAW264.7 macrophages. ATP7A RNAi- and control RNAi-
transfected cells were stimulated overnight with IFN- (mean S.D.; n 3).
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of macrophages (68, 69). Our findings underscore the possibil-
ity that these changes in systemic copper concentrations may
provide localized reserves of copper for macrophage-mediated
bactericidal activity.
Acknowledgments—We thank Dennis Thiele for anti-CTR1 anti-
serum and Marc Solioz for providing the copA mutant E. coli strain.
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